Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan

Paper. Raffa RB. Cureus, 13 Sep 2026.

Tags: Review, Psilocybin, MDMA, LSD, Ibogaine, Depression, Addiction.

Weekly Science Digest, 12 Sep 2026 to 18 Sep 2026, finding 5: In brief

Regulatory knock-on: what a near-term US approval of psilocybin or noribogaine would mean for Japan's narcotics scheduling and pharmacy practice

Read the original

—
Node—
Statuslive
Throughput—